US EditionPublished • loading... • Updated
Teva Pharmaceutical Industries (NYSE:TEVA) Reaches New 52-Week High – Still a Buy?
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Teva Pharmaceutical Industries (NYSE:TEVA) Reaches New 52-Week High – Still a Buy?
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as $26.42 and last traded at $26.3160, with a volume of 9750265 shares trading hands. The stock had previously closed at $24.99. Analyst Ratings Changes Several equities research analysts recently weighed […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
